Albarico, Virgilio P.
HRN: 25-30-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2024
MUPIROCIN 2%, 15G (TUBE)
06/18/2024
06/25/2024
INTRADERMA
Apply To Affected Area
BID
For HD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes